Comprehensive liver protection when fatty liver threatens your health. Addresses the root cause — gut-derived inflammation that drives fatty liver progression.
☆☆☆☆☆No reviews yet16-week minimum course recommended for NAFLD/NASH with liver enzyme monitoring — C. butyricum butyrate provides dual gut barrier repair and hepatic HDAC inhibition for profibrotic pathway suppression.
NAFLD is a hepatology-focused synbiotic designed as an adjunct for managing Non-Alcoholic Fatty Liver Disease (NAFLD), NASH, and associated gut conditions including Crohn’s disease, ulcerative colitis, and C. difficile-associated diarrhoea.
It combines four clinically selected probiotic strains — Streptococcus faecalis, Clostridium butyricum, Bacillus mesentericus, and Bacillus coagulans — with Vitamin C and a postbiotic fraction to precisely target the gut-liver axis.
“NAFLD is a hepatology-focused synbiotic designed as an adjunct for managing Non-Alcoholic Fatty Liver Disease (NAFLD), NASH, and associated gut conditions including Crohn’s disease, ulcerative colitis, and C.”
Lorbiotics NAFLD · Hepatology
The documented biological pathway — exactly how each component acts inside the body.
In NAFLD, gut dysbiosis increases intestinal permeability (“leaky gut”), allowing excess LPS, microbial metabolites, and secondary bile acids to enter the portal vein. This triggers hepatic inflammation via TLR-4 activation on Kupffer cells, promoting progression from simple steatosis to NASH and fibrosis.
NAFLD interrupts this process at multiple levels:
Clostridium butyricum — the gut’s premier butyrate producer — strengthens the intestinal barrier (reducing LPS translocation) and acts as a potent HDAC inhibitor in the liver, suppressing profibrotic pathways in hepatic stellate cells.
The Bacillus species provide spore stability and broad-spectrum antimicrobials that help restore a healthier, butyrate-rich microbiome.
Together, the multi-strain blend delivers synergistic, multi-point modulation of the gut-liver axis that single-strain probiotics cannot achieve.
Bacillus mesentericus: Proteolytic & lipolytic enzymes to control putrefactive bacteria
Bacillus coagulans: Lactic acid + bacteriocins for colonization resistance
Postbiotic fraction: Rapid anti-inflammatory PRR activation to calm Kupffer cells
Vitamin C: Supports hepatic detoxification and antioxidant protection
Perfect for premium liver and gut-liver axis formulations.
The exact composition of Lorbiotics NAFLD — each organism and active listed at its formulated dose.
| Organism / active | Documented role | Dose |
|---|---|---|
| Streptococcus fecalis | — | 2 B CFU |
| Clostridium butyricum | — | 3 B CFU |
| Bacillus mesentericus | — | 3 B CFU |
| Bacillus coagulans | — | 3 B CFU |
| Postbiotic fraction as standardized | — | — |
| Vitamin C | Ascorbic acid | 80 mg |
1–2 sachets/capsules daily, with meals. For NAFLD/NASH: minimum 16-week course with liver enzyme monitoring. Or as advised by hepatologist / physician.
Capsule / Sachet · 60 per Pack
With postbiotic fraction and Vitamin C 80 mg for hepatic antioxidant and immune support.
Reviews come from verified buyers only. Once customers who've purchased NAFLD share their experience, you'll see it here.
Every claim on this page traces back to published literature. The full citation list for Lorbiotics NAFLD.
